RESUMO
Gastoesophageal reflux disease [GERD] is one of the most common gastrointestinal diseases encountered in today's clinic practice. GERD symptoms are troublesome and disruptive to the physical, social and emotional well-being of many patients. This is a cross-sectional study performed on Qashqai nomads or Fars Province in southern Ian to determine the impact of GERD on quality of life. We randomly selected 748 subjects over the age of25 years. Subjects completed two questionnaires conducted by interviews. The first one consisted of questions on gastroesophageal reflux symptoms. The second questionnaire was the Short Form Health Survey [SF-36], a generic health-related quality of life instrument that consists of 36 items divided into eight dimensions. It has a 0-to 100 point scale where higher scores show better functioning and well-being. Of 748 Qashqai migrating nomads who participated in the study, 717 subjects [mena age: 43 +/- 14.2 years] completed the GERD questionnaire and only 372 subjects completed the SF-36 questionnaire due to their busy lifestyles, and GERD was reported in 106 subjects [28.5%]. For all dimensions of SF-36, the mean score was consistently lower in patients with GERD was reported in 106 subjects [28.5%]. For all dimensions of SF-36, the mean score was consistently lower in patients with GERD compared to non-GERD subjects [P<0.001]. The dimension most frequently impaired was role-physical [40.9 vs. 77.3] followed by role-emotional [44.7 vs. 77.5], physical functioning [66.9 vs. 84.6], and general health [46.8 vs. 63.8]. An association existed between impairment in quality of life and frequency [P<0.05], but not severity, of GERD symptoms
RESUMO
Hepatitis B virus [HBV] infection is still reported from adult hemodialysis units. To determine the prevalence of anti-HBs antibody in hemodialysis patients and the correlation between levels of anti-HBs antibody with other factors. HBsAg, anti-HBs and anti-HBc antibodies level in 199 hemodialysis patients were evaluated by enzyme-linked immunosorbent assay. Seroconversion [antiHBs antibody >10 IU/L] was found in 22 patients. Minimum protective antibody level was found in patients aged >/= 60 years. Statistically significant correlation was not found between anti-HBs antibody and gender. Ten [8.4%] patients had abnormal ALT and/or AST. Prevalence of HBsAg, anti-HBc antibody, HBeAg and anti-HBe antibody were found in 8 [6.72%], 24 [25.16%], 2 [1.685] and 3 [2.52%] patients, respectively. periodic assessment of anti-HBs antibody level is strongly recommended in patients undergoing hemodialysis